Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04534218
Title Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer (REPROGRAM-01)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Hospitalier Universitaire de Besancon
Indications

colorectal cancer

Therapies

Aspirin + Capecitabine + Cyclophosphamide + Regorafenib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.